Format (l x h) : 210 x 280 mm
| Editeur : ELSEVIER
| Date de publication : 01/1956
| Nombre de volume : 201 volume(s)
| Périodicité : 10 n° par an
| Langue(s) de publication : Anglais
An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- ...en savoir plus
An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.
An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.
Sommaire du dernier numéro paru:
Editorial Board
Targeting endothelial cytoskeletal remodeling to restore angiogenesis in ischemic heart disease
Transferrin-functionalized liposomes for targeted breast cancer therapy: Mechanistic insights, conjugation strategies, and translational evidence
Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases
The key to obesity leading to atherosclerosis: Why we should pay attention to the perivascular adipose tissue (PVAT)
Tryptophan metabolism as a key integrator within the gut-lung-brain axis: Mechanistic insights and nutritional therapeutic strategies for inflammatory and neuropsychiatric disorders
Neuroinflammation and mononuclear phagocytes in glaucoma: From ocular pathogenesis to central visual pathway involvement — A comprehensive review
Lupeol in neurodegenerative and neuropsychiatric disorders: Mechanisms and translational perspectives
Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis
Sphingosine-1-phosphate: Mechanisms and therapeutic potential in wound repair
Natural bioactive compounds: Properties and health advantages against numerous medical conditions with a special focus on endometriosis management
Resistance-centered pharmacology of DNA damage response-targeted therapy: Mechanisms, predictive biomarkers, and biomarker-guided adaptive treatment strategies in solid tumors
The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies
Cell-penetrating peptides (CPPs)-engineered PLGA nanocarriers for enhanced drug delivery: Uptake mechanisms, optimization strategies, and therapeutic applications
Bacoside-A from Bacopa monnieri (L.) Wettst. in Parkinson’s disease: In Silico and preclinical insights into dopaminergic neuroprotection
Nanoparticles – polyphenol and flavonoid plants for diabetic wounds
CGRP–uric acid axis in migraine: A redox–inflammatory framework linking neurovascular signaling and metabolic regulation
Innovations in peptide-based targeted therapies for breast cancer: From conjugates to precision delivery
Clinical development in primary mitochondrial diseases at a translational inflection point: Lessons, mechanisms, and emerging therapeutic strategies
Next-generation drug delivery systems for aspergillosis: Overcoming barriers in antifungal therapy
Decoding the pathogenesis of Candida albicans infection and evaluating the efficacy of antifungal drugs using atomic force microscopy
Smart biomaterials in the dimensional revolution of bioprinting: From 2D to 6D for advanced biomedical applications
Malvidin and its glycosides in cancer treatment: Mechanisms, synergies and drug delivery strategies
CAR-T cell therapy and oncolytic viruses: A synergic approach for advanced GI cancers
From diabetic foot to dementia: A neurovascular continuum linking systemic diabetic vasculopathy, cerebral small vessel disease, and glymphatic dysfunction
Unleashing the prospects of nanomaterials in the treatment of autoimmune and inflammatory diseases
Stem cell-derived exosome therapy for traumatic brain injury and its auditory complications
Iron biomarkers for prognosis, diagnosis, and therapeutic insight in colorectal cancer
Bidirectional microbiota-cancer crosstalk: Emerging platforms for advanced diagnostics and precision therapeutics in oncology
Biomaterials for women’s health: Recent progress in nanomaterials and innovative therapies for endometriosis treatment
Intravenous immunoglobulin therapy in viral infections: Lessons learned from COVID-19
Telomir-Zn restores glucose homeostasis and reduces insulin resistance in a diet-induced zebrafish model of type 2 diabetes
Interleukin-8 and extracellular vesicles spread senescence in Lymphangioleiomyomatosis microenvironment
Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer
Discovery of bridged melanostatin derivatives as potent allosteric modulators of the dopamine D2 receptors with improved permeability
SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis
20(S)-hydroxycholesterol, a natural allosteric agonist of Smoothened, exerts neuroprotective effects associated with angiogenesis and vascular plasticity following ischemia
Cordycepin attenuates nicotine-induced behavioral sensitization through inhibition of NF-κB signaling in rats
Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia
Luteolin from Lonicera japonica Thunb. restores GLUT4-mediated glucose uptake via PI3K/Akt signaling in insulin resistance
Linker-dependent variations in the tumoricidal activity of DZ-1–dihydroartemisinin conjugate formats
Baicalein blocks ethanol effects on dopamine transmission in the mesolimbic system and ethanol self-administration
Tailoring PRGF fibrin membranes: A simple approach to enhance structural and functional properties for wound healing
Acoustic cluster therapy mediated enhancement of [68Ga]Ga-PSMA-617 in a murine glioblastoma multiforme model verified by simultaneous PET/MRI
Synbiotics and antioxidants synergistically attenuate disease progression in metabolic dysfunction-associated steatotic liver disease
D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease
Vericiguat, a soluble guanylate cyclase stimulator, regulates heart failure–enhanced atrial and pulmonary vein arrhythmogenesis
A six-proline stabilized trimeric spike DNA vaccine induces robust immunity and protects against SARS-CoV-2 delta challenge in K18-hACE2 transgenic mice
Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation
Anxiety-related platform in zebrafish (Danio rerio) larvae: An integrated analysis of behavioural and molecular assay in drug screening research
Administration of Pgk1 missense mutation leads to more effective mitigation of neurodegenerative effects observed in ALS mice and transgenic zebrafish
A juglone derivative that disrupts mitochondrial redox metabolism, inhibiting the breast fibroblast-cancer cell pro-migratory signaling induced by doxorubicin
Oral ceramide attenuates ultraviolet B-induced epidermal dysregulation and hyperpigmentation by modulating MITF signaling and barrier-related pathways
Hepatoprotective effects of the branched-chain fatty acids 12-methylmyristic and 13-methylmyristic against palmitate-induced lipotoxicity
The novel biguanide SD282 suppresses autoimmune rheumatoid arthritis by controlling the Th17/Treg balance and restoring mitochondrial homeostasis via STAT3 regulation
GLP-1 receptor agonist-induced transient retinal perfusion delay and its potential mediation by intracranial pressure
Fabrication of stable chitosan-liposomes via flash nanoprecipitation for efficient fluconazole encapsulation
Luteolin attenuates vascular-renal dysfunction and fibrosis in hypertensive rats by targeting oxidative stress, inflammation, and fibrotic pathways
Comprehensive vasodilatory and antihypertensive effects of 3,7,3′,4′-tetrahydroxyflavone (fisetin): Ex vivo and in vivo evidence
DHA-loaded nanocapsules enhance microcirculation and reduce inflammation in sepsis experimental model
A potent and selective PHOX2B promoter-driven oncolytic adenovirus for targeted neuroblastoma therapy
Repurposing of cyclophosphamide as a chemo‑immunotherapy agent in glioma using D8/RI‑VAP modified-chitosan nanoparticles
Salivary gland extract from Ornithodoros brasiliensis disrupts adhesion-dependent behavior in neuroblastoma cells
Transcriptome profiling identifies RET activation as a therapeutic target in gastric-type endocervical adenocarcinoma
Famotidine-conjugated green silver nanoparticles as a selective anticancer and antibacterial nanomedicine
Effects of SGLT2 inhibitor dapagliflozin on the heart of rats with long-standing Type 1 diabetes mellitus: Protein profile
Targeting the fusion machinery of Peste des petits ruminants virus: design and in vitro characterization of an HRC-derived antiviral peptide
A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model
Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress
Euphol targets key oncogenic processes and promotes chemoprevention in organoid and In Vivo models of colorectal cancers
Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells
Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling
Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors
Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs
Wnt activation during epileptogenesis prevents pathological immature dentate granule cell morphological changes in animal models of unilateral and bilateral temporal lobe epilepsy
Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D
From DNA-encoded library (DEL) screening to in vivo validation: LILRB4 (ILT3)-targeted small molecules reprograms myeloid immune suppression
Inhibition of the ZEB1–BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma
Comparative in vitro evaluation of fourth-generation anti-GPC3 CAR T-cells in hepatocellular carcinoma
Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40/GPR120 ligands
Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir
Extracellular vesicle depletion improves transient gene expression performance and alters cellular transcriptional responses in CHO cell
Effect of electron beam irradiation of piroxicam on inhibiting the inflammatory response in LPS-stimulated BMDCs and sepsis-induced mouse models
Antitumor efficacy of repurposed phenformin in preclinical models of epithelial ovarian cancer
RGD-functionalized cannabidiol lipid nanoparticles improve brain delivery and alleviate cognitive and metabolic dysfunction via gut-brain axis modulation in an Alzheimer's disease model
Cardioprotective potential of Fridericia platyphylla (Cham.) L.G. Lohmann: Phytochemical characterization and experimental evidence
DDAH1 and DDAH2 drive vasculogenic mimicry and more aggressive phenotypes in triple negative breast cancer cells
Aerobic conditioning and ginsenoside modulation modify molecular resilience in middle-aged rats: Differential effects of individual and combined interventions
Preliminary electrochemical study of Ap3A and Ap4A potential role in enhancing allicin-induced DNA denaturization and susceptibility to structure damage
Cuminaldehyde alleviates inflammation in isoproterenol-induced acute myocardial infarction through Nrf-2/HO-1 and NF-κB signaling pathways
Amelioration of obesity-induced testicular dysfunction and structural damage by ganoderma lucidum polysaccharides and triterpenoids in rats: Correlation with Nrf2-mediated antioxidant response
Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia
Corrigendum to “Microenvironment-responsive sodium alginate hydrogel loaded with MnO2 and pachymic acid for the treatment of gastric ulcer” [Biomed. Pharmacother. 183 (2025) 117835]
Corrigendum to in vivo effects of a selected thiourea derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) against nociception, inflammation and gastric ulcerogenicity: Biochemical, histopathological and in silico approaches [Biomed. Pharmacother. 174 (2024) 116544]
Corrigendum to “Neuroprotective effects of platinum nanoparticle-based microreactors in a pilocarpine-induced rat model of epilepsy” [Biomed. Pharmacother. 200 (2026) 119552]
Corrigendum to “Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells” [Biomed. Pharmacother. 189 (2025) 118279]
Corrigendum to “Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats” [Biomed. Pharmacother. 81 (2016) 93–103]
Corrigendum: “Zebrafish as a model to study inflammation: A tool for drug discovery” [Biomed. Pharmacother. 144 (2021) 112310]
Corrigendum: "Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments" [BIOPHA 176 (2024) 116808]
Corrigendum to ‘A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis)’ [Biomed. Pharmacother. 181 (2024) 117706]
Corrigendum to “Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)” [Biomed. Pharmacother. 200 (2026), 119609]
Corrigendum to “Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization” [Biomed. Pharmacother. 141 (2021) 111883]
Corrigendum to “Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes”[Biomed. Pharmacother. 176 (2024) 116814]
Retraction notice to "Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson’s disease and cell culture via inactivating TLR4/NF-κB pathway" [Biomedicine & Pharmacotherapy 97 (2018) 1011-1019]
Retraction notice to "Bougainvillea flower extract mediated zinc oxide’s nanomaterials for antimicrobial and anticancer activity" [Biomedicine & Pharmacotherapy 116 (2019) 108983]
Retraction notice to "Corrigendum to “vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats” [Biomed. Pharmacother. 96 (2017) 667–674]" [Biomedicine & Pharmacotherapy 165 (2023) 115061]
Retraction notice to "Vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats" [Biomedicine & Pharmacotherapy 96(2017) 667-678]
Retraction notice to "Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications" [Biomedicine & Pharmacotherapy 162 (2023) 114687]
Retraction notice to "Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway" [Biomedicine & Pharmacotherapy 176 (2024) 116836]
Retraction notice to "The dual gastro- and neuroprotective effects of curcumin loaded chitosan nanoparticles against cold restraint stress in rats" [Biomedicine & Pharmacotherapy 148 (2022) 112778]
Retraction notice to "Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways" [Biomedicine & Pharmacotherapy 161 (2023) 114512]
Retraction notice to "Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications" [Biomedicine & Pharmacotherapy 145 (2022) 112419]
Retraction notice to "Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers" [Biomedicine & Pharmacotherapy 181 (2024) 117714]
Retraction notice to "Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications" [Biomedicine & Pharmacotherapy 99 (2018) 1022-1032]
Retraction notice to "Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators" [Biomedicine & Pharmacotherapy 114 (2019) 108777]
Retraction notice to "Corrigendum to “Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators” [Biomed. Pharmacother. 114 (2019) 108777]" [Biomedicine & Pharmacotherapy 186 (2025) 117988]
Retraction notice to "SNP alleviates mitochondrial homeostasis dysregulation-mediated developmental toxicity in diabetic zebrafish larvae" [Biomedicine & Pharmacotherapy 177 (2024) 117117]
Retraction notice to "Effect of bone marrow mesenchymal stem cells-derived exosomes on diabetes-induced retinal injury: Implication of Wnt/ b-catenin signaling pathway" [Biomedicine & Pharmacotherapy 154 (2022) 113554]
Retraction notice to "Nephroprotective potential of Panduratin A against colistin-induced renal injury via attenuating mitochondrial dysfunction and cell apoptosis" [Biomedicine & Pharmacotherapy 148 (2022) 112732]
Retraction notice to "Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy" [Biomedicine & Pharmacotherapy 145 (2022) 112122]
Retraction notice to "Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation" [Biomedicine & Pharmacotherapy 155 (2022) 113740]
Retraction notice to "Molecular insights into experimental models and therapeutics for cholestasis" [Biomedicine & Pharmacotherapy 174 (2024) 116594]
Retraction notice to "Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine" [Biomedicine & Pharmacotherapy 166 (2023) 115301]
Expression of concern: “Design and synthesis of benzo[d]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease" [Biomed. Pharmacother. 156 (2022) 113838]
Editor note to article entitled “Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets” [Biomed. Pharmacother. 145 (2022), 112420]
Editor note to article entitled “The emerging role of PANoptosis in cancer treatment” [Biomed. Pharmacother. 168 (2023), 115696]
Editor note to article entitled “Phytoestrogens, novel dietary supplements for breast cancer” [Biomed. Pharmacother. 160 (2023), 114341]
Editor note to article entitled “Steviol glycosides from Stevia rebaudiana Bertoni mitigate lipid metabolism abnormalities in diabetes by modulating selected gene expression – An in vivo study” [Biomed. Pharmacother. 166 (2023), 115424]
Editor note to article entitled “Protective effect of esculentoside A against myocardial infarction via targeting C-X-C motif chemokine receptor 2” [Biomed. Pharmacother. 174 (2024), 116529]
Editor note to article entitled “Curcumin: An epigenetic regulator and its application in cancer” [Biomed. Pharmacother. 156 (2022), 113956]
Editor note to article entitled “Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies” [Biomed. Pharmacother. 165, (2023) 115242]
Editor Note to article entitled “Mdivi-1, a mitochondrial fission inhibitor, reduces angiotensin-II- induced hypertension by mediating VSMC phenotypic switch” [Biomed. Pharmacother. 140 (2021) 111689]
Editor Note to article entitled “Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase” [Biomed. Pharmacother. 169 (2023), 115908]
Editor note to article entitled ‘Biochemical and tissue physiopathological evaluation of the preclinical efficacy of Solanum torvum Swartz leaves for treating oxidative impairment in rats administered a β-cell-toxicant (STZ)’[Biomedicine & Pharmacotherapy 154 (2022) 113605]
Editor Note to article entitled ‘Protective effects of CoQ10 and L-carnitine against antidepressant-induced mitochondrial dysfunction and teratogenicity in chicken embryos’ [Biomed. Pharmacother. 184 (2025) 117882]
Editor Note to article entitled ‘Cryo-EM structure of HMGB1-RAGE complex and its inhibitory effect on lung cancer’ [Biomed. Pharmacother. 187 (2025) 118088]
Seuls les utilisateurs munis d'un compte client peuvent laisser un commentaire. Veuillez vous connecter ou créer un compte s'il vous plait.
product
https://www.elsevier-masson.fr/biomedicine-pharmacotherapy.html310920Biomedicine & Pharmacotherapyhttps://www.elsevier-masson.fr/media/catalog/product/y/b/ybm_1.jpg933933EURInStock/Autres disciplines/Biologie/Médecine/Biologie/Médecine/Biologie/Bactériologie/maladies infectieuses/Revues/Product Format/journals/Product Format/Journals/Product Format/Journals/Product Format/Journals/Product Format/Journals/Product Format/Revistas/Product Format/Zeitschrift2846357888285934440285265936792593984959398505939851593985259398536165527128204284622837159367913593680174535936778373593678274545936780105595936787278705936814An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. <strong><i>Biomedicine and pharmacotherapy</i></strong> is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.00148136Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierFrance (+ DOM-TOM)12 mois148137Biomedicine & Pharmacotherapy952.59952.59https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierUE (+ Suisse)12 mois148138Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierReste du monde12 mois148139Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantFrance (+ DOM-TOM)12 mois148140Biomedicine & Pharmacotherapy952.59952.59https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantUE (+ Suisse)12 mois148141Biomedicine & Pharmacotherapy933933https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantReste du monde12 mois148142Biomedicine & Pharmacotherapy10681068https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionFrance (+ DOM-TOM)12 mois148143Biomedicine & Pharmacotherapy1155.771155.77https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionUE (+ Suisse)12 mois148144Biomedicine & Pharmacotherapy13311331https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionReste du monde12 mois148145Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierFrance (+ DOM-TOM)24 mois148146Biomedicine & Pharmacotherapy1905.181905.18https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierUE (+ Suisse)24 mois148147Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierReste du monde24 mois148148Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantFrance (+ DOM-TOM)24 mois148149Biomedicine & Pharmacotherapy1905.181905.18https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantUE (+ Suisse)24 mois148150Biomedicine & Pharmacotherapy18661866https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantReste du monde24 mois148151Biomedicine & Pharmacotherapy21362136https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionFrance (+ DOM-TOM)24 mois148152Biomedicine & Pharmacotherapy2311.542311.54https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionUE (+ Suisse)24 mois148153Biomedicine & Pharmacotherapy26622662https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionReste du monde24 mois148154Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierFrance (+ DOM-TOM)36 mois148155Biomedicine & Pharmacotherapy2857.772857.77https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierUE (+ Suisse)36 mois148156Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueParticulierReste du monde36 mois148157Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantFrance (+ DOM-TOM)36 mois148158Biomedicine & Pharmacotherapy2857.772857.77https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantUE (+ Suisse)36 mois148159Biomedicine & Pharmacotherapy27992799https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueÉtudiantReste du monde36 mois148160Biomedicine & Pharmacotherapy32043204https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionFrance (+ DOM-TOM)36 mois148161Biomedicine & Pharmacotherapy3467.313467.31https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionUE (+ Suisse)36 mois148162Biomedicine & Pharmacotherapy39933993https://www.elsevier-masson.fr/media/catalog/product/https://www.elsevier-masson.fr/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockRevue - NumériqueInstitutionReste du monde36 mois2011 and earlier1Revue210 x 280 mmELSEVIER1 janv. 1956EN STOCK20110 n° par anRevueAnglaisRevue - Numériquehttp://www.em-consulte.com/produit/biophaAutres disciplines, Biologie, Biologie/Bactériologie/maladies infectieuses, Médecine, JournalsNonEditorial Board | Targeting endothelial cytoskeletal remodeling to restore angiogenesis in ischemic heart disease | Transferrin-functionalized liposomes for targeted breast cancer therapy: Mechanistic insights, conjugation strategies, and translational evidence | Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases | The key to obesity leading to atherosclerosis: Why we should pay attention to the perivascular adipose tissue (PVAT) | Tryptophan metabolism as a key integrator within the gut-lung-brain axis: Mechanistic insights and nutritional therapeutic strategies for inflammatory and neuropsychiatric disorders | Neuroinflammation and mononuclear phagocytes in glaucoma: From ocular pathogenesis to central visual pathway involvement — A comprehensive review | Lupeol in neurodegenerative and neuropsychiatric disorders: Mechanisms and translational perspectives | Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis | Sphingosine-1-phosphate: Mechanisms and therapeutic potential in wound repair | Natural bioactive compounds: Properties and health advantages against numerous medical conditions with a special focus on endometriosis management | Resistance-centered pharmacology of DNA damage response-targeted therapy: Mechanisms, predictive biomarkers, and biomarker-guided adaptive treatment strategies in solid tumors | The Warburg effect and beyond: Glycolytic reprogramming in cancer progression and emerging therapeutic strategies | Cell-penetrating peptides (CPPs)-engineered PLGA nanocarriers for enhanced drug delivery: Uptake mechanisms, optimization strategies, and therapeutic applications | Bacoside-A from <i>Bacopa monnieri</i> (L.) <i>Wettst.</i> in Parkinson’s disease: <i>In Silico</i> and preclinical insights into dopaminergic neuroprotection | Nanoparticles – polyphenol and flavonoid plants for diabetic wounds | CGRP–uric acid axis in migraine: A redox–inflammatory framework linking neurovascular signaling and metabolic regulation | Innovations in peptide-based targeted therapies for breast cancer: From conjugates to precision delivery | Clinical development in primary mitochondrial diseases at a translational inflection point: Lessons, mechanisms, and emerging therapeutic strategies | Next-generation drug delivery systems for aspergillosis: Overcoming barriers in antifungal therapy | Decoding the pathogenesis of <i>Candida albicans</i> infection and evaluating the efficacy of antifungal drugs using atomic force microscopy | Smart biomaterials in the dimensional revolution of bioprinting: From 2D to 6D for advanced biomedical applications | Malvidin and its glycosides in cancer treatment: Mechanisms, synergies and drug delivery strategies | CAR-T cell therapy and oncolytic viruses: A synergic approach for advanced GI cancers | From diabetic foot to dementia: A neurovascular continuum linking systemic diabetic vasculopathy, cerebral small vessel disease, and glymphatic dysfunction | Unleashing the prospects of nanomaterials in the treatment of autoimmune and inflammatory diseases | Stem cell-derived exosome therapy for traumatic brain injury and its auditory complications | Iron biomarkers for prognosis, diagnosis, and therapeutic insight in colorectal cancer | Bidirectional microbiota-cancer crosstalk: Emerging platforms for advanced diagnostics and precision therapeutics in oncology | Biomaterials for women’s health: Recent progress in nanomaterials and innovative therapies for endometriosis treatment | Intravenous immunoglobulin therapy in viral infections: Lessons learned from COVID-19 | Telomir-Zn restores glucose homeostasis and reduces insulin resistance in a diet-induced zebrafish model of type 2 diabetes | Interleukin-8 and extracellular vesicles spread senescence in Lymphangioleiomyomatosis microenvironment | Steryl glucosides as a novel chemosensitizer: Enhancing doxorubicin response in estrogen receptor-positive breast cancer | Discovery of bridged melanostatin derivatives as potent allosteric modulators of the dopamine D<sub>2</sub> receptors with improved permeability | SU056 potentiates SULF2 antibody in suppressing cholangiocarcinoma metastasis via SULF2-YBX1-CXCR4 signaling axis | 20(S)-hydroxycholesterol, a natural allosteric agonist of Smoothened, exerts neuroprotective effects associated with angiogenesis and vascular plasticity following ischemia | Cordycepin attenuates nicotine-induced behavioral sensitization through inhibition of NF-κB signaling in rats | Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia | Luteolin from <i>Lonicera japonica</i> Thunb. restores GLUT4-mediated glucose uptake via PI3K/Akt signaling in insulin resistance | Linker-dependent variations in the tumoricidal activity of DZ-1–dihydroartemisinin conjugate formats | Baicalein blocks ethanol effects on dopamine transmission in the mesolimbic system and ethanol self-administration | Tailoring PRGF fibrin membranes: A simple approach to enhance structural and functional properties for wound healing | Acoustic cluster therapy mediated enhancement of [<sup>68</sup>Ga]Ga-PSMA-617 in a murine glioblastoma multiforme model verified by simultaneous PET/MRI | Synbiotics and antioxidants synergistically attenuate disease progression in metabolic dysfunction-associated steatotic liver disease | D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease | Vericiguat, a soluble guanylate cyclase stimulator, regulates heart failure–enhanced atrial and pulmonary vein arrhythmogenesis | A six-proline stabilized trimeric spike DNA vaccine induces robust immunity and protects against SARS-CoV-2 delta challenge in K18-hACE2 transgenic mice | Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation | Anxiety-related platform in zebrafish (<i>Danio rerio</i>) larvae: An integrated analysis of behavioural and molecular assay in drug screening research | Administration of Pgk1 missense mutation leads to more effective mitigation of neurodegenerative effects observed in ALS mice and transgenic zebrafish | A juglone derivative that disrupts mitochondrial redox metabolism, inhibiting the breast fibroblast-cancer cell pro-migratory signaling induced by doxorubicin | Oral ceramide attenuates ultraviolet B-induced epidermal dysregulation and hyperpigmentation by modulating MITF signaling and barrier-related pathways | Hepatoprotective effects of the branched-chain fatty acids 12-methylmyristic and 13-methylmyristic against palmitate-induced lipotoxicity | The novel biguanide SD282 suppresses autoimmune rheumatoid arthritis by controlling the Th17/Treg balance and restoring mitochondrial homeostasis via STAT3 regulation | GLP-1 receptor agonist-induced transient retinal perfusion delay and its potential mediation by intracranial pressure | Fabrication of stable chitosan-liposomes via flash nanoprecipitation for efficient fluconazole encapsulation | Luteolin attenuates vascular-renal dysfunction and fibrosis in hypertensive rats by targeting oxidative stress, inflammation, and fibrotic pathways | Comprehensive vasodilatory and antihypertensive effects of 3,7,3′,4′-tetrahydroxyflavone (fisetin): <i>Ex vivo</i> and <i>in vivo</i> evidence | DHA-loaded nanocapsules enhance microcirculation and reduce inflammation in sepsis experimental model | A potent and selective <i>PHOX2B</i> promoter-driven oncolytic adenovirus for targeted neuroblastoma therapy | Repurposing of cyclophosphamide as a chemo‑immunotherapy agent in glioma using D8/RI‑VAP modified-chitosan nanoparticles | Salivary gland extract from <i>Ornithodoros brasiliensis</i> disrupts adhesion-dependent behavior in neuroblastoma cells | Transcriptome profiling identifies RET activation as a therapeutic target in gastric-type endocervical adenocarcinoma | Famotidine-conjugated green silver nanoparticles as a selective anticancer and antibacterial nanomedicine | Effects of SGLT2 inhibitor dapagliflozin on the heart of rats with long-standing Type 1 diabetes mellitus: Protein profile | Targeting the fusion machinery of Peste des petits ruminants virus: design and in vitro characterization of an HRC-derived antiviral peptide | A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model | Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress | Euphol targets key oncogenic processes and promotes chemoprevention in organoid and <i>In Vivo</i> models of colorectal cancers | Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells | Microfluidic human liver slices reveal antifibrotic effects of liraglutide via HSC deactivation and ECM remodeling | Photocontrol of zebrafish behavior with a photoswitchable ligand of nicotinic acetylcholine receptors | Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs | Wnt activation during epileptogenesis prevents pathological immature dentate granule cell morphological changes in animal models of unilateral and bilateral temporal lobe epilepsy | Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D | From DNA-encoded library (DEL) screening to in vivo validation: LILRB4 (ILT3)-targeted small molecules reprograms myeloid immune suppression | Inhibition of the ZEB1–BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma | Comparative <i>in vitro</i> evaluation of fourth-generation anti-GPC3 CAR T-cells in hepatocellular carcinoma | Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40/GPR120 ligands | Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir | Extracellular vesicle depletion improves transient gene expression performance and alters cellular transcriptional responses in CHO cell | Effect of electron beam irradiation of piroxicam on inhibiting the inflammatory response in LPS-stimulated BMDCs and sepsis-induced mouse models | Antitumor efficacy of repurposed phenformin in preclinical models of epithelial ovarian cancer | RGD-functionalized cannabidiol lipid nanoparticles improve brain delivery and alleviate cognitive and metabolic dysfunction via gut-brain axis modulation in an Alzheimer's disease model | Cardioprotective potential of <i>Fridericia platyphylla</i> (Cham.) L.G. Lohmann: Phytochemical characterization and experimental evidence | DDAH1 and DDAH2 drive vasculogenic mimicry and more aggressive phenotypes in triple negative breast cancer cells | Aerobic conditioning and ginsenoside modulation modify molecular resilience in middle-aged rats: Differential effects of individual and combined interventions | Preliminary electrochemical study of Ap<sub>3</sub>A and Ap<sub>4</sub>A potential role in enhancing allicin-induced DNA denaturization and susceptibility to structure damage | Cuminaldehyde alleviates inflammation in isoproterenol-induced acute myocardial infarction through Nrf-2/HO-1 and NF-κB signaling pathways | Amelioration of obesity-induced testicular dysfunction and structural damage by ganoderma lucidum polysaccharides and triterpenoids in rats: Correlation with Nrf2-mediated antioxidant response | Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia | Corrigendum to “Microenvironment-responsive sodium alginate hydrogel loaded with MnO<sub>2</sub> and pachymic acid for the treatment of gastric ulcer” [Biomed. Pharmacother. 183 (2025) 117835] | Corrigendum to in vivo effects of a selected thiourea derivative 1-(2-chlorobenzoyl)-3-(2,3-dichlorophenyl) against nociception, inflammation and gastric ulcerogenicity: Biochemical, histopathological and in silico approaches [Biomed. Pharmacother. 174 (2024) 116544] | Corrigendum to “Neuroprotective effects of platinum nanoparticle-based microreactors in a pilocarpine-induced rat model of epilepsy” [Biomed. Pharmacother. 200 (2026) 119552] | Corrigendum to “Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells” [Biomed. Pharmacother. 189 (2025) 118279] | Corrigendum to “Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats” [Biomed. Pharmacother. 81 (2016) 93–103] | Corrigendum: “Zebrafish as a model to study inflammation: A tool for drug discovery” [Biomed. Pharmacother. 144 (2021) 112310] | Corrigendum: "Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments" [BIOPHA 176 (2024) 116808] | Corrigendum to ‘A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis)’ [Biomed. Pharmacother. 181 (2024) 117706] | Corrigendum to “Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)” [Biomed. Pharmacother. 200 (2026), 119609] | Corrigendum to “Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization” [Biomed. Pharmacother. 141 (2021) 111883] | Corrigendum to “Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes”[Biomed. Pharmacother. 176 (2024) 116814] | Retraction notice to "Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson’s disease and cell culture via inactivating TLR4/NF-κB pathway" [Biomedicine & Pharmacotherapy 97 (2018) 1011-1019] | Retraction notice to "<i>Bougainvillea</i> flower extract mediated zinc oxide’s nanomaterials for antimicrobial and anticancer activity" [Biomedicine & Pharmacotherapy 116 (2019) 108983] | Retraction notice to "Corrigendum to “vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats” [Biomed. Pharmacother. 96 (2017) 667–674]" [Biomedicine & Pharmacotherapy 165 (2023) 115061] | Retraction notice to "Vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats" [Biomedicine & Pharmacotherapy 96(2017) 667-678] | Retraction notice to "Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications" [Biomedicine & Pharmacotherapy 162 (2023) 114687] | Retraction notice to "Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway" [Biomedicine & Pharmacotherapy 176 (2024) 116836] | Retraction notice to "The dual gastro- and neuroprotective effects of curcumin loaded chitosan nanoparticles against cold restraint stress in rats" [Biomedicine & Pharmacotherapy 148 (2022) 112778] | Retraction notice to "Targeting oncogenic functions of <i>miR-301a</i> in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways" [Biomedicine & Pharmacotherapy 161 (2023) 114512] | Retraction notice to "Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications" [Biomedicine & Pharmacotherapy 145 (2022) 112419] | Retraction notice to "Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers" [Biomedicine & Pharmacotherapy 181 (2024) 117714] | Retraction notice to "Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications" [Biomedicine & Pharmacotherapy 99 (2018) 1022-1032] | Retraction notice to "Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from <i>Magnolia officinalis</i> in 3<sup>rd</sup> degree burn mice by inhibiting inflammatory mediators" [Biomedicine & Pharmacotherapy 114 (2019) 108777] | Retraction notice to "Corrigendum to “Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from <i>Magnolia officinalis</i> in 3rd degree burn mice by inhibiting inflammatory mediators” [Biomed. Pharmacother. 114 (2019) 108777]" [Biomedicine & Pharmacotherapy 186 (2025) 117988] | Retraction notice to "SNP alleviates mitochondrial homeostasis dysregulation-mediated developmental toxicity in diabetic zebrafish larvae" [Biomedicine & Pharmacotherapy 177 (2024) 117117] | Retraction notice to "Effect of bone marrow mesenchymal stem cells-derived exosomes on diabetes-induced retinal injury: Implication of Wnt/ b-catenin signaling pathway" [Biomedicine & Pharmacotherapy 154 (2022) 113554] | Retraction notice to "Nephroprotective potential of Panduratin A against colistin-induced renal injury via attenuating mitochondrial dysfunction and cell apoptosis" [Biomedicine & Pharmacotherapy 148 (2022) 112732] | Retraction notice to "Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia/reperfusion-induced lesion through modulation of HMGB1/TLR4/NF-κB signaling and autophagy" [Biomedicine & Pharmacotherapy 145 (2022) 112122] | Retraction notice to "Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation" [Biomedicine & Pharmacotherapy 155 (2022) 113740] | Retraction notice to "Molecular insights into experimental models and therapeutics for cholestasis" [Biomedicine & Pharmacotherapy 174 (2024) 116594] | Retraction notice to "Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine" [Biomedicine & Pharmacotherapy 166 (2023) 115301] | Expression of concern: “Design and synthesis of benzo[<i>d</i>]thiazol-2-yl-methyl-4-(substituted)-piperazine-1-carbothioamide as novel neuronal nitric oxide inhibitors and evaluation of their neuroprotecting effect in 6-OHDA-induced unilateral lesioned rat model of Parkinson's disease" [Biomed. Pharmacother. 156 (2022) 113838] | Editor note to article entitled “Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets” [Biomed. Pharmacother. 145 (2022), 112420] | Editor note to article entitled “The emerging role of PANoptosis in cancer treatment” [Biomed. Pharmacother. 168 (2023), 115696] | Editor note to article entitled “Phytoestrogens, novel dietary supplements for breast cancer” [Biomed. Pharmacother. 160 (2023), 114341] | Editor note to article entitled “Steviol glycosides from <i>Stevia rebaudiana</i> Bertoni mitigate lipid metabolism abnormalities in diabetes by modulating selected gene expression – An <i>in vivo</i> study” [Biomed. Pharmacother. 166 (2023), 115424] | Editor note to article entitled “Protective effect of esculentoside A against myocardial infarction <i>via</i> targeting C-X-C motif chemokine receptor 2” [Biomed. Pharmacother. 174 (2024), 116529] | Editor note to article entitled “Curcumin: An epigenetic regulator and its application in cancer” [Biomed. Pharmacother. 156 (2022), 113956] | Editor note to article entitled “Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies” [Biomed. Pharmacother. 165, (2023) 115242] | Editor Note to article entitled “Nuclear factor erythroid 2-related factor 2 agonist protects retinal ganglion cells in glutamate excitotoxicity retinas” [Biomed. Pharmacother. 153 (2022) 113378] | Editor Note to article entitled “Mdivi-1, a mitochondrial fission inhibitor, reduces angiotensin-II- induced hypertension by mediating VSMC phenotypic switch” [Biomed. Pharmacother. 140 (2021) 111689] | Editor Note to article entitled “Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase” [Biomed. Pharmacother. 169 (2023), 115908] | Editor note to article entitled ‘Biochemical and tissue physiopathological evaluation of the preclinical efficacy of <i>Solanum torvum</i> Swartz leaves for treating oxidative impairment in rats administered a β-cell-toxicant (STZ)’[Biomedicine & Pharmacotherapy 154 (2022) 113605] | Editor Note to article entitled ‘Protective effects of CoQ10 and L-carnitine against antidepressant-induced mitochondrial dysfunction and teratogenicity in chicken embryos’ [Biomed. Pharmacother. 184 (2025) 117882] | Editor Note to article entitled ‘Cryo-EM structure of HMGB1-RAGE complex and its inhibitory effect on lung cancer’ [Biomed. Pharmacother. 187 (2025) 118088]Caoût 2026Revue - Numérique<ul><li>10 n° par an </li><li>Application iPhone/iPad</li><li>Début de l'abonnement : maximum 48h après réception du paiement.</li></ul>NonNonNonNonVeuillez sélectionnerVeuillez sélectionnerNonNonVeuillez sélectionner
